2022
DOI: 10.1016/j.radonc.2021.12.045
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of ultra-high versus conventional dose rate radiotherapy in a patient with cutaneous lymphoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
36
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 52 publications
(40 citation statements)
references
References 16 publications
(39 reference statements)
0
36
0
Order By: Relevance
“…Recently, radiation oncology departments worldwide have started implementing this technology at multiple levels geared toward early phase clinical trials in humans. To this end, a feasibility study with one patient has been published ( 9 ) recently followed by a negative report ( 10 ). In the same patient with a cutaneous lymphoma, no difference in terms of side effects and tumor response when a single dose of 15 Gy when delivered at 166 Gy/s versus conventional (0.08 Gy/s) dose rate.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, radiation oncology departments worldwide have started implementing this technology at multiple levels geared toward early phase clinical trials in humans. To this end, a feasibility study with one patient has been published ( 9 ) recently followed by a negative report ( 10 ). In the same patient with a cutaneous lymphoma, no difference in terms of side effects and tumor response when a single dose of 15 Gy when delivered at 166 Gy/s versus conventional (0.08 Gy/s) dose rate.…”
Section: Introductionmentioning
confidence: 99%
“…The results of the treatment were favorable where the patient exhibited no decrease in skin thickness and an equivalent tumor control compared to previously administered CONV-RT treatments [ 53 ]. In a different study on the same patient, two distinct tumors were treated to a dose of 15 Gy single fraction using either CONV or FLASH dose rates [ 54 ]. Both treatments gave comparable results in terms of acute and late effects as well as tumor control.…”
Section: Clinical Experiences With Flash-rtmentioning
confidence: 99%
“…The FLASH effect has been demonstrated in several animal studies of various types (fish eggs, mice, cats, mini‐pigs, etc. ), 2–7 and a first patient (skin melanoma) has been treated recently 8,9 . Although some FLASH effects have been also observed with photon 10 and proton 11 beams, the most established demonstrations were obtained with low‐energy electron beams (<20 MeV), limiting their current application to superficial tumors.…”
Section: Introductionmentioning
confidence: 99%
“…), [2][3][4][5][6][7] and a first patient (skin melanoma) has been treated recently. 8,9 Although some FLASH effects have been also observed with photon 10 and proton 11 beams, the most established demonstrations were obtained with low-energy electron beams (<20 MeV), limiting their current application to superficial tumors. New developments in compact highgradient accelerator techniques [12][13][14] and laser-driven electron beam technologies [15][16][17] allow to consider the use of very high-energy electron (VHEE, E > 70 MeV) beams [18][19][20] to address the penetration depth limitation and exploit the FLASH effect for the treatment of deepseated tumors.…”
Section: Introductionmentioning
confidence: 99%